Syneos Health announced the appointment of Terttu Haring, MD, as President, Clinical Sites & Patients. With nearly 30 years of experience, Dr. Haring will lead the global clinical operations organization to drive exceptional delivery, quality and data integrity for customers, while ensuring a positive experience for sponsors, sites and patients. Her investigator background, and technology and data experience, will empower the Clinical Sites & Patients team to execute data-driven solutions that produce strong results for customers.

Under Dr. Haring?s guidance, Syneos Health will continue to nurture its heritage of scientific and therapeutic expertise across global clinical operations. Dr. Haring will also empower the Clinical Sites & Patients team to leverage the Company?s in-depth local regulatory experience, with its expanding global footprint, to better connect patients and sites worldwide. Fueled by advanced data, analytics and insights from sources such as Syneos Health?s Patient Voice Consortium, the team is leveraging technology and deep enterprise expertise to execute more representative clinical trial research.

Based in Amsterdam, Netherlands, Dr. Haring?s appointment adds to a growing team of global therapeutic experts at Syneos Health who design and execute fit-for-purpose solutions that deliver high-quality results for customers across the clinical to commercial continuum. With decades of pharma and CRO experience, Dr. Haring most recently held multiple leadership roles at Sanofi, with escalating responsibility across Clinical Research, Trial Operations and Data Management, and Clinical Innovation. She began her research career at Kendle International, a CRO acquired by INC Research, which then became Syneos Health.